Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"This study was supported by Shanghai Municipal Natural Science Foundation (Project Number: 09ZR1417900), Leading academic discipline project of Shanghai Municipal Education Committee (Project Number: J50208), Shanghai Pujiang Program (Project Number: 11PJ1406500), and the National Natural Science Funds (Project Number: 81102015)."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025